nadolol ( 8 mg/kg , intravenously ) ( n = 10 ) reduced ventricular arrhythmias during both phases of arrhythmia development and increased survival ( 70 % , p = 0.001 vs control ) .
C0085612
ventricular arrhythmias
C0003811
arrhythmia